Fatal Anaphylactic Sting Reaction in a Patient with MastocytosisWagner N.a · Fritze D.b · Przybilla B.c · Hagedorn M.a · Ruëff F.c
aHautklinik und bMedizinische Klinik, Klinikum Darmstadt, Darmstadt, und cKlinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität, München, Deutschland Int Arch Allergy Immunol 2008;146:162–163 (DOI:10.1159/000113520)
We report on a 33-year-old female patient with indolent systemic mastocytosis and urticaria pigmentosa who died of an anaphylactic reaction after a yellow jacket sting. As she had no history of previous anaphylactic sting reaction, there was no testing performed in order to detect hymenoptera venom sensitization. But even if a sensitization had been diagnosed, no venom immunotherapy (VIT) would have been recommended. It is almost certain that VIT would have saved her life and it is most likely that VIT is indicated in some patients with mastocytosis with no history of anaphylactic sting reaction. However, no criteria have been established in order to allow a selection of mastocytosis patients eligible for such a ‘prophylactic’ VIT.
|Direct payment||This item at the regular price: USD 33.00|
|Payment from account||With a Karger Pay-per-View account (down payment USD 150)
you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00